Le Lézard
Classified in: Health
Subjects: NPT, PER

The diaTribe Foundation Appoints Jim Carroll CEO


SAN FRANCISCO, April 13, 2021 /PRNewswire/ -- The diaTribe Foundation, a San Francisco-based nonprofit dedicated to diabetes education and advocacy, announced today that Jim Carroll, the organization's chief operating and financial officer, has been promoted to the new role of chief executive officer.

"Since The diaTribe Foundation was created in 2012, it has become an essential nexus of information, advocacy, and connection in the diabetes community," said Kelly Close, founder and Chair of the Board of The diaTribe Foundation. "Jim has been a huge part of our success, and as our new CEO, his vision, his commitment to public health, and his leadership will take us to new heights and allow us to reach more people with diabetes. His passion, drive and energy are truly inspirational." 

During the past two years, Carroll has overseen record expansion at diaTribe, growing its annual revenue by more than 70 percent to $3.6 million last year. He launched a multi-stakeholder initiative to make Time in Range an essential and accessible part of diabetes care, as well as a movement to address and reduce diabetes stigma.  

"I am honored that Kelly Close and our Board of Directors have given me the opportunity to lead our amazing staff and volunteers at diaTribe to help everyone with diabetes," Carroll said. "Our fight against diabetes stigma and for the adoption of Time in Range as a global metric, as well as the weekly publication diaTribe Learn gives me a great reason to jump out of bed every morning and get to work!"

Prior to joining diaTribe in 2019, Carroll spent seven years as vice president of finance and administration at Common Sense Media, during which time its revenue doubled, and before that was managing director of Equality California for six years, where he led the team to successfully pass over 70 pieces of legislation to achieve legal equality for LGBT Californians. 

Carroll, a graduate of the University of Florida and Florida native, has also worked at The Breast Cancer Fund and at the national office of Parents, Families and Friends of Lesbians and Gays. He lives with his husband, Scott, and their two yellow Labrador Retrievers in San Francisco. 

"Jim Carroll's extensive experience as a leader in several impactful nonprofit organizations provides him with all the tools that will be required to bring the diaTribe Foundation to the next level of influence in the world of diabetes," said board member Alan Moses, former Senior Vice President and Chief Medical Officer of the Joslin Diabetes Center and Senior Vice President and Global Chief Medical Office at Novo Nordisk.

The mission of The diaTribe Foundation is to improve the lives of people affected by diabetes and pre-diabetes, and to advocate for action. It publishes diaTribe Learn, a patient-focused online resource, which provides actionable advice to make people healthier and happier and give them hope for the future.

 

SOURCE The diaTribe Foundation


These press releases may also interest you

at 08:07
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has released a comprehensive contract research organization (CRO) offering tailor-made for sponsors looking to bring diagnostic products...

at 08:05
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in a pilot study collecting patient-generated health data (PGHD) during proton radiotherapy for lung cancer in...

at 08:05
Roivant and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for...

at 08:05
Revvity, Inc. will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV. Senior Vice President and Chief Financial Officer Max Krakowiak will provide an update on the Company and its...

at 08:05
Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on developing next-generation neuropsychiatric therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has notified the...

at 08:05
Microbion Corporation today announced that the company won the Advanced Wound Care Summit's Innovation Showcase award. The Innovation Showcase was designed to give presenters, who were picked by a selection committee, an opportunity to demonstrate...



News published on and distributed by: